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Abstract We have studied the contribution of P-type voltage- 
dependent Ca 2+ channels to both catacholamine (CA) and ATP 
secretion from bovine chromaffin cells induced by high K ÷ or 
nicotine using ¢o-agatoxin IVA, a selective blocker of P-type 
voltage-dependent Ca 2÷ channels. We found that high K ÷ (75 
raM) induced the release of about 13% of norepinephrine, 5% 
epinephrine and 11% ATP, and that ¢o-agatoxin (100 nM) did not 
affect this secretion. However, both nicotine-induced CA and 
ATP secretion were significantly blocked (about 50%) by 
¢o-agatoxin IVA (100 nM). In addition, this toxin also reversibly 
blocked (about 70%) the inward current induced by nicotine in 
bovine chromaffin cells. The results suggest that, besides its 
known action of blocking P-type voltage-dependent channels, 
¢o-agatoxin is a potent and reversible blocker of the nicotinic 
receptor channel in chromaffin cells, and that this action would 
explain the blockade of nicotine-induced secretion. 
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1. Introduction 
Adrenomedullary chromaffin cells secrete catecholamines in 
response to nicotinic cholinergic agonists [1-3]. Following acti- 
vation of the nicotinic receptor, a non-selective cation channel, 
associated to the receptor, opens [4,5], and the membrane of 
chromaffin cells is depolarized [6-8]. This depolarization leads 
to the opening of voltage-dependent Na+ and Ca 2+ channels 
located on the plasma membrane that elevate [Ca2+]i, which 
induces catecholamine (CA) secretion. Using electrophysiologi- 
cal techniques, the presence of L- [9,10], N- [11] and P- [12] type 
voltage-dependent Ca 2+ channels located on the plasma mem- 
brane of chromaffin cells has been demonstrated. 
P-Type voltage-dependent Ca 2+ channels have been de- 
scribed to carry a significant amount of voltage-activated Ca2+ 
current in different neural cells [13-15], and have also been 
implicated in neurotransmitter secretion in different systems 
[16,17]. In adrenergic tissues, P-type voltage-dependent Ca2+ 
channels seem to contribute significantly to Ca 2+ currents in 
response to depolarization [12]. However, its participation in 
the secretory process is less clear, although a fraction of the 
funnel-web spider poison (FTX) can partially block both the 
increase in intracellular Ca 2+ levels and CA secretion in re- 
sponse to K+-induced epolarization [18]. 
*Corresponding author. Fax: (34) (6) 565 5218. 
In the present work, we have attempted to characterize the 
contribution of P-type voltage-dependent Ca 2+ channels to CA 
and ATP secretion from bovine chromaffin cells induced by 
either depolarization with high extracellular K + or by nicotinic 
receptor activation, by using the toxin o)-agatoxin IVA (o)- 
AgaTx), obtained from a peptide fraction of the funnel-web 
spider, Agenelopsis aperta, that is considered to be a specific 
blocker of P-type voltage-dependent Ca 2+ channels [13]. 
2. Materials and methods 
2.1. Cell culture 
Chromaffin cells were isolated as previously described [19] with 
minor modifications. Briefly, glands were perfused through the adre- 
nolumbar vein with CaZ÷-free Locke's olution of the following compo- 
sition (in mmol/l): NaC1, 154; KCI, 5.6; MgC12, 1; NaH2PO4, 3; HEPES, 
10; and glucose, 10. The pH of the solution was adjusted to 7.4 with 
NaOH. The glands were then digested with Locke's olution containing 
0.2% collagenase (Boehringer-Mannheim, Indianapolis, IN) and 0.5% 
bovine serum albumin (Calbiochem, La Jolla, CA) and incubated for 
45 min at 37°C. Next, the medulla was separated from the cortex, 
minced with scissors and further digested in the presence of collagenase 
at 37°C for an additional 30 min. After filtering through a nylon mesh, 
chromaffin cells were separated from erythrocytes u ing a Percoll gra- 
dient. The yield varied between 20 and 30 x 106 cells per gland and the 
viability was greater than 95% as defined by exclusion of the biological 
dye Trypan blue. Cells were cultured in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal calf serum (FCS) under 
an atmosphere of 5% CO2. 
2.2. Catecholamine secretion 
After 3-7 days of culture, chromaffin cells were washed for 60 rain 
(12 x 5 min) with 800/.d Krebs-HEPES (K-H) of the following compo- 
sition (in mmol/1): NaCI, 140; KC1, 5.9; MgSO4, 1.2; CaC12, 2.5; 
HEPES, 15; and glucose, 11; pH was adjusted to a value between 7.3 
and 7.4. After washing, a 5 min sample was taken to determine basal 
CA release. The solution in the well was changed, for 5 min, to one 
containing the desired secretagogue, either high K ÷ or nicotine. A final 
5 min sample was taken following the 5 min period of stimulation. 
Samples were kept on ice-cold water and quickly acidified with per- 
chloric acid (PCA) to a final concentration of 0.05 N. To determine 
total CA cell content at the end of the experiment, 800 ¢tl of PCA 
(0.05 N) was added to each well. High K ÷ solution was prepared by 
isosmotically substituting NaC1 by KCI. o)-Agatoxin IVA, when pres- 
ent, was added 5 min before, and maintained through, the stimulus. 
Fractional release was calculated by dividing the total amount of either 
norepinephrine (NE) or epinephrine (E) released uring a 5 min period 
by the total amount of that amine present at the beginning of that 
particular period of time. Individual net fractional release was calcu- 
lated for each period either during the secretory stimulus or 5 min after 
the stimulus, by subtracting the release during the basal 5 min period. 
Total net fractional release was calculated by adding individual net 
fractional releases during and 5 rain after K ÷ stimulation. 
CA release was determined using a HPLC system with electrochem- 
ical detection, provided with two Gilson pumps (model 303), two 
Gilson automatic njectors, two amperometric detectors (Model LC4B, 
Bioanalytical Systems, West Lafayette, IN and model 656, Metrohm, 
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Switzerland with voltages et at 0.65 V and 0.9 V, respectively). Signals 
recorded from the detectors were integrated, the area under the peaks 
measured and the CA concentration calculated from internal standards 
using a Gilson software (model 714). The precolumn and the analytical 
columns were identical in both systems and consisted of a replaceable 
cartridge reverse-phase C]s precolumn (5 ,urn particle size, 30 × 4 mm 
i.d.; Macherey-Nagel, Duren, Germany) and an analytical reverse- 
phase C]8 replaceable cartridge column (5/.tm particle size, 100 × 4 mm 
i.d.; Machinery-Nagel, Duren, Germany). Flow was set at 1 ml/min and 
100 pl samples were injected. The mobile phase was similar to the one 
previously described [20] and had the following composition (in 
mmol/1): NaHzPO4, 80; EDTA, 0.13; heptane sulfonic acid, 5; methanol 
10%, the pH was adjusted to 3 with orthophosphoric a id. Retention 
times were 5.1 rain for NE and 7.9 min for E. 
2.3. Electrophysiological recording 
Recording of chromaffin cell nicotinic receptor currents under volt- 
age-clamp was done as previously described [4] with some modifica- 
tions. Chromaffin cells were bathed in a solution with the following 
ionic composition (in mmol/1): NaCl, 140; KCI, 5.9; CaCl2, 2.5; MgCh_, 
1; HEPES, 10; glucose, 11 (pH 7.4). The ionic composition of the 
pipette solution was the following (in mmol/1): KCI, 40; K2SO4, 50; 
MgSO4, 7; HEPES, 10 and nystatin, 250/lg/ml (pH 7.2). A high resis- 
tance seal was established in the cell-attached configuration (open tip 
resistance of the pipette ranged between 3 and 5 Mr2). Capacity tran- 
sients were canceled using the built-in circuitry of the patch-clamp 
amplifier (EPC-7; List, Darmstadt, Germany) and the pipette potential 
set at -55 mV. After 2 or 3 min a small capacity transient indicating 
electrical continuity between the cell interior and pipette solution was 
observed. The size of the transient stabilized about 5 min after forma- 
tion of the gigaseal. Nicotine (10pM) was applied for 3.5 s using a fast 
perfusion system (DAD-12; Adams & List, NY) 10 min after gigaseal 
formation. Nicotine (10 pM) application was repeated 3 times (S~, $2, 
$3) with an interval of 15 min. The average capacitance of the cells was 
11.1 + 0.99 pF and the series resistance (Rs) 9.8 + 0.9 M/2 (n = 12). No 
compensation for Rs was used. When used, co-AgaTx or D-tubocurarine 
were perfused to the cell 5 s before and during $2. 
2.4. ATP determination 
ATP release in response to high K + or nicotine was determined using 
the luciferin luciferase method as previously described [3]. Total ATP 
content in the cell was determined by solubilizing the cells using Ex- 
tralight (Analytical Luminescence, San Diego, CA). 
2..5. Chemicals 
Culture reagents were obtained from Gibco. Nicotine was purchased 
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Fig. 1. Effect of to-agatoxin IVA on high K+-induced NE, E and ATP 
secretion. Secretion of norepinephrine (NE), epinephrine (E) and ATP 
after exposure of bovine chromaffin cells to high extracellular K + (75 
mM) for 5 min in the absence (open bars) and in the presence (filled 
bars) of to-agatoxin (100 nM). Data represent mean _+ S.E.M. of 
7 experiments for NE and E secretion and 28 for ATE 
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Fig. 2. Effect of m-agatoxin IVA on nicotine-induced NE, E and ATP 
secretion. Secretion of norepinephrine (NE), epinephrine (E) and ATP 
after exposure of bovine chromaffin cells to nicotine (10/~M) for 5 rain 
in the absence (open bars) and in the presence (filled bars) ofto-agatoxin 
IVA (100 nM). Data represent mean + S.E.M. of 8 experiments. 
*P < 0.01 as compared to control. 
from Sigma and co-Agatoxin IVA was obtained from RBI (Natick, 
MA). All other reagents were obtained from commercial sources and 
were of the highest quality available. 
3. Results and discussion 
Two different populations of chromaffin cells preferentially 
secreting NE and E have been described in bovine adrenal 
medulla [21,22]. Exposure of bovine chromaffin cells in culture 
to high extracellular K ÷ (75 mM) induced the release of about 
13% of the total NE and 5% of total E content in the cells 
(n = 7) (Fig. 1). High K + (75 mM) induced the release of 12% 
of total ATP present in chromaffin cells (n = 28). There is a 
good correlation between CA and ATP secretion, as would be 
expected since the more likely source of released ATP in re- 
sponse to depolarization is the chromaffin granule where it is 
co-stored with CA [23,24]. In the presence of 100 nM of m- 
AgaTx, a dose high enough to completely block P-type voltage- 
dependent Ca 2+ channels [25], CA or ATP secretion induced by 
high K ÷ (75 mM) were not affected (Fig. 1). This suggests that 
although about 50% of the Ca 2+ entering bovine chromaffin 
cells following a depolarizing pulse is sensitive to co-AgaTx [12], 
P-type Ca 2+ channels are not involved in either CA or ATP 
secretion in response to depolarization. 
The physiological stimulus for CA and ATP secretion in the 
adrenal medulla is acetylcholine that activates cholinergic nico- 
tinic receptors [1]. Exposure of bovine chromaffin cells to the 
nicotinic cholinergic agonist nicotine (10 pM) induced the se- 
cretion of 30 + 1.8% of total NE and 17.9 + 1.6% of total E 
present in chromaffin cells at the beginning of the stimulation 
(n -- 8) (Fig. 2). Nicotine treatment also induced the release of 
8.4 + 0.6% of total ATP present in the cells (n = 8) (Fig. 2). 
m-AgaTx (100 nM) decreased by about 40% nicotine-induced 
NE and E release (Fig. 2). In addition, nicotine-induced ATP 
secretion was significantly blocked (about 60%) by m-AgaTx 
(100 nM) (Fig. 2). These results suggest that voltage-dependent 
P-type Ca 2+ channels are selectively coupled, in bovine chro- 
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Fig. 3. Effect of co-agatoxin IVA on nicotine-induced currents. Inward current induced by 3 consecutive applications of nicotine (10/IM) with an 
interval of 15 min as described in section 2. The second application of nicotine was done in the presence of to-agatoxin IVA (100 nM). The figure 
represents a typical experiment that was repeated 4 times with similar esults. 
maffin cells, to nicotine-induced secretion. This indicates that 
P channels are located in the vicinity of the nicotinic receptor 
and so would be preferentially activated by nicotinic stimula- 
tion. This suggests that P-type voltage-dependent Ca 2÷ chan- 
nels may play a role in secretion in chromaffin cells similar to 
other systems [26,27]. However, since co-AgaTx did not affect 
high K+-induced secretion, an effect of the toxin on a target 
different from voltage-dependent P-type Ca 2÷ channels hould 
be excluded. 
Nicotine-induced secretion from chromaffin cells begins by 
activation of nicotinic receptors that increase the permeability 
to Na ÷ and K + ions and very little, under physiological concen- 
trations of extracellular Na +, to Ca 2+ [4]. This change in perme- 
ability depolarizes chromaffin cells and produces opening of 
voltage-dependent Ca 2+ channels. Although og-AgaTx is con- 
sidered a highly selective blocker of P-type voltage-dependent 
Ca 2+ channels [13], we decided to investigate the effect of this 
toxin on the current induced by activation of nicotinic receptors 
to exclude the possibility that the nicotinic receptor could be 
a primary target for co-AgaTx. If this is the case it could explain 
the selective inhibitory action of the toxin on nicotine-induced 
secretion without affecting high K÷-induced secretion. 
To explore this possibility we decide to use nystatin-perfo- 
rated patch-clamp recordings to preserve physiological regula- 
tion of the cell, and use a holding potential of -55 mV that is 
Table 1 
Effect of agatoxin IVA and D-tubocurarine onnicotine-induced inward 
currents and net charge influx in bovine chromaffin cells 
Drug added together 
with nicotine during $2 
Peak current Total net charge 
(S2/St ratio) influx 
($2/S 1 ratio) 
None 10 0.81 _+ 0.12 0.55 + 0.05 
og-AgaTx 1 nM 3 0.48 _+ 0.06* 0.39 + 0.05* 
to-AgaTx 10 nM 4 0.26 + 0.07** 0.15 _+ 0.06** 
¢o-AgaTx 100 nM 4 0.34 _+ 0.04** 0.18 + 0.04** 
D-Tubocurarine 10 ktM 3 0.10 _+ 0.02*** 0.09 + 0.04*** 
Bovine chromaffin cells were exposed for 3.5 s to nicotine (10/.tM) as 
stated in section 2. Nicotine stimulation was repeated 3 times (S~, $2, 
$3) at 15 min interval, o-Tubocurarine or og-AgaTx IVA were perfused 
to the cell 5 s before and during the second (Sz) nicotine stimulation. 
The average value for inward peak current and total net charge influx 
during S~ were -204 + 25 pA (n = 23) and 256 + 19 pC (n = 23). Data 
represent mean + S.E.M. *P < 0.05; **P < 0.005; ***P < 0.001 as 
compared to control. 
the resting membrane potential measured under current-clamp 
conditions (data not shown). Perfusion of bovine chromaffin 
cells under voltage-clamp with nicotine (10/IM) for 3.5 s in- 
duced an inward current that amounted to -204 + 25 pA 
(n = 23) (Fig. 3). That current inactivated quickly with a time 
constant of about 1 s. Peak current was very little affected by 
a second exposure of the cell to nicotine (10/~M), with a SJS1 
ratio of 0.81 + 0.12 (Table 1). However, in the presence of 
o~-AgaTx, peak current was markedly decreased in a dose- 
dependent manner ($2/$1 ratio of 0.34 + 0.04 in the presence of 
co-AgaTx 100 nM; Fig. 3). In addition, nicotine-evoked inward 
current was almost completely blocked by the nicotinic recep- 
tor antagonist D-tubocurarine (Table 1). The time integral on 
the current gives the total amount of charge entering the cell 
during the first nicotine stimulation (S 0 as 256.5 _+ 19.2 pC 
(n = 23). When nicotine perfusion was repeated 15 min later, 
about 35% of inactivation was observed (SJS~ ratio for the total 
charge of 0.55 + 0.05). However, when, after an initial exposure 
to nicotine (10/.tM) for 3.5 s, a second perfusion with nicotine 
was repeated 15 min later in the presence of og-AgaTx, a dose- 
dependent blocking action of og-AgaTx could be observed 
(Table 1). Consistent with its effect on peak current, the nico- 
tinic receptor blocker D-tubocurarine blocked net charge influx 
in response to nicotine. The blocking effect of both og-AgaTx 
(Fig. 3) and D-tubocurarine (data not shown) could be partially 
reverted by washing out the toxin or the drug. 
The data indicate that besides its known action as a blocker 
of P-type voltage-dependent Ca 2+ channels [14,25], og-AgaTx is 
a very potent blocker of the neuronal cholinergic nicotinic 
receptor present in bovine chromaffin cells and that its blocking 
actions on nicotine-induced secretion might be explained, not 
by a specific location of P-type voltage-dependent Ca 2+ chan- 
nels close to nicotinic receptors, but rather by a specific revers- 
ible blockade of agonist-induced current hrough the nicotinic 
receptor channels. The blocking effect of og-AgaTx on nicotinic 
receptor channels is shared by different compounds, including 
somatostatin [28], methoxyverapamil [29] and atropine [30], 
suggesting that nicotinic receptor function might be regulated 
by multiple pathways. 
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